USA: Researchers have found in a new study that adjuvant radiotherapy (RT) or endocrine therapy (ET) significantly reduces ...

“ounger patients with low genomic risk breast cancer may reasonably consider de-escalated adjuvant therapy,” the researchers wrote.

Claudine Isaacs, MD: For this patient who's progressed after more than 12 months with an ESR1 mutation and HER2-low disease ...

In breast cancer patients with a high recurrence score, the 5-year disease-free rate was significantly higher for patients receiving taxanes with anthracycline and cyclophosphamide than for those ...

The partners aim to retrospectively identify predictive and prognostic breast cancer biomarkers using data from multiple randomized trials.